An atypical insulin receptor with high affinity for insulin-like growth factors copurified with placental insulin receptors.

Similar Items

• Disulphide reduction alters the immunoreactivity and increases the affinity of insulin-like growth-factor-I receptors in human placenta.
  od: Jonas, H A, i dr.
  Izdano: (1986)
• Delineation of atypical insulin receptors from classical insulin and type I insulin-like growth factor receptors in human placenta.
  od: Jonas, H A, i dr.
  Izdano: (1989)
• High-affinity insulin binding to an atypical insulin-like growth factor-I receptor in human breast cancer cells.
  od: Milazzo, G, i dr.
  Izdano: (1992)
• Purified hybrid insulin/insulin-like growth factor-I receptors bind insulin-like growth factor-I, but not insulin, with high affinity.
  od: Soos, M A, i dr.
  Izdano: (1993)
• Insulin-like growth factor binding to the atypical insulin receptors of a human lymphoid-derived cell line (IM-9).
  od: Jonas, H A, i dr.
  Izdano: (1990)